Auris Medical Holding Ltd. (NASDAQ: EARS) is 48.47% higher on its value in year-to-date trading and has touched a low of $0.73 and a high of $6.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EARS stock was last observed hovering at around $3.22 in the last trading session, with the day’s gains setting it 0.67% off its average median price target of $14.30 for the next 12 months. It is also 72.8% off the consensus price target high of $14.30 offered by 1 analysts, but current levels are 72.8% higher than the price target low of $14.30 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $3.89, the stock is 5.15% and 10.28% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 49.41 million and changing 20.81% at the moment leaves the stock 100.99% off its SMA200. EARS registered 378.95% gain for a year compared to 6-month gain of 377.30%. The firm has a 50-day simple moving average (SMA 50) of $3.6332 and a 200-day simple moving average (SMA200) of $2.3845.
The stock witnessed a -25.19% loss in the last 1 month and extending the period to 3 months gives it a 51.36%, and is 11.78% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.24% over the week and 12.63% over the month.
Auris Medical Holding Ltd. (EARS) has around 12 employees, a market worth around $52.20M and $0.19M in sales. Distance from 52-week low is 436.18% and -41.06% from its 52-week high.
Auris Medical Holding Ltd. (EARS) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Auris Medical Holding Ltd. (EARS) is a “Buy”. 1 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Auris Medical Holding Ltd. is expected to release its quarterly report on 08/19/2021 and quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $59.1M over the same period..
Auris Medical Holding Ltd. (EARS) Top Institutional Holders
10 institutions hold shares in Auris Medical Holding Ltd. (EARS), with 569.87k shares held by insiders accounting for 4.43% while institutional investors hold 1.52% of the company’s shares. The shares outstanding are 13.42M, and float is at 12.61M with Short Float at 3.90%. Institutions hold 1.46% of the Float.
The top institutional shareholder in the company is Virtu Financial LLC with over 63920.0 shares valued at $0.17 million. The investor’s holdings represent 0.50% of the EARS Shares outstanding. As of Dec 30, 2020, the second largest holder is Renaissance Technologies, LLC with 63020.0 shares valued at $0.17 million to account for 0.49% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 21727.0 shares representing 0.17% and valued at over $56924.0, while Envestnet Asset Management holds 0.10% of the shares totaling 12450.0 with a market value of $32619.0.